TiGenix opens US headquarters
TiGenix NV announces it has opened an U.S. office in Cambridge Massachusetts. Establishing U.S. operations is a significant step for TiGenix and will support its strategic goal of developing and...
View ArticleSoligenix Announces 1 for 20 ReverseSplit of its Common Stock
PRINCETON N.J. Feb. 1 2012 PRNewswire Soligenix Inc. OTCBB SNGXD Soligenix or the Company a development stage biopharmaceutical company announced it has filed a Certificate of Amendment to its Amended...
View ArticleSoligenix Demonstrates Positive Proof of Concept with its Proprietary Vaccine...
PRINCETON N.J. Feb. 6 2012 PRNewswire Soligenix Inc. OTCBB SNGXD Soligenix or the Company a development stage biopharmaceutical company announced today results from preclinical studies of its...
View ArticleMylan Completes Acquisition of Two LimitedCompetition Dermatological Products...
PITTSBURGH Feb. 6 2012 PRNewswire &160;Mylan Inc. Nasdaq MYL today announced that it has successfully completed the acquisition of two dermatological products from Valeant Pharmaceuticals. Mylan...
View ArticlePfizer and Mount Sinai Renew Agreement to Identify New Drug Candidates
NewsMount Sinai Pfizer renew research collaboration building on strong foundation. The researchers take aim at major diseases such as cancer rheumatoid arthritis Crohn's disease colitis heart failure...
View ArticlePatient Engagement Physician Journey and Patient Journey New Pharma Studies...
Regulatory pressures and constantly changing market dynamics have made it imperative for the healthcare industry to introduce innovations frequently and strive towards better clinical outcomes. To...
View ArticleSoligenix Announces Results From Its Phase 12 Clinical Trial of SGX201 for...
PRINCETON N.J. Feb. 10 2012 PRNewswire Soligenix Inc. OTCBB SNGXD Soligenix or the Company a development stage biopharmaceutical company announced preliminary results today from a Phase 12 clinical...
View ArticleIMMUNE Pharmaceuticals' Oncology Subsidiary CYTOVIA Announces Additional...
NEW YORK July 5 2017 PRNewswire Cytovia the oncology subsidiary of Immune Pharmaceuticals Inc. a clinical stage biopharmaceutical company NASDAQ IMNP "Immune" or the "Company" announced the publication...
View ArticleGalapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year
With the addition of uveitis Galapagos and Gilead are raising to 10 the number of indications in filgotinib&8217;s clinical pipeline. Galapagos and Gilead clearly have big expectations for...
View ArticleCoronado Biosciences to Present at the Rodman & Renshaw Annual Global...
NEW YORK Sept. 6 2011 PRNewswire Coronado Biosciences Inc. the "Company" a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases...
View ArticleTummy troubles NBC News touts hypnosis as the answer for millions
NBC Nightly News wants you to know this &8220;Hypnotherapy can be an effective treatment for heartburn and other stomach conditions. It&8217;s a powerful alternative treatment backed with...
View ArticleViaDerma Inc. will Seek BFAD Bureau of Food and Drugs Approval for its...
LOS ANGELES CAMarketwired July 10 2017 ViaDerma Inc. OTC PINK VDRM a specialty pharmaceutical company devoted to bringing new products to market recently announced today that the Company seeks to...
View ArticleGlobal and Chinese Morbus Crohn Industry 2017 Market Research Report Report...
The 'Global and Chinese Morbus Crohn Industry 20122022 Market Research Report' is a professional and indepth study on the current state of the global Morbus Crohn industry with a focus on the Chinese...
View ArticleNektar Presents New Preclinical Data for NKTR358 a FirstinClass Regulatory T...
SAN FRANCISCO July 10 2017 PRNewswire Nektar Therapeutics NASDAQ NKTR today announced positive preclinical results for NKTR358 a firstinclass resolution therapeutic for autoimmune disease. The new...
View ArticleArena Pharmaceuticals Reports Positive Topline Phase 2 Results for Ralinepag...
SAN DIEGO July 10 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced positive Phase 2 results for ralinepag an investigational longacting orally administered prostacyclin receptor...
View ArticleProvention Bio Inc. Appoints Eleanor L. Ramos MD as Chief Medical Officer and...
LEBANON N.J. July 11 2017 PRNewswire Provention Bio Inc. a clinicalstage biopharmaceutical company dedicated to sourcing developing and commercializing novel therapeutics aimed at intercepting and...
View ArticleProbiotics May Have Benefits for UC but Not Crohn's
A probiotic called VSL3 may be effective in inducing remission in active ulcerative colitis UC according to findings from a new systematic review and metaanalysis. Reuters Health Information
View ArticleGreen Relief Welcomes Medical Marijuana Patients
KISSIMMEE Fla. July 11 2017 PRNewswire Green Relief is located across the street from Florida Hospital in Kissimmee and is now accepting medical marijuana patients. New rules for Medical Marijuana go...
View ArticleRedHill Biopharma Announces Expected Timeline For DSMB Meeting And Provides...
Life Sciences Jobs ...
View Article